Synthetic method of oxidafluorine derivative

By optimizing the synthesis route of olaflu, using the reaction of R-X with 1,3-propanediamine, Lewis acid and hydrofluoric acid, the existing oloxol impurity problem was solved, and high purity and high yield were achieved The synthesis of olaflu derivatives provides a reliable reference for olaflu quality control, ensuring the safety and accuracy of the product.

CN119059922AActive Publication Date: 2024-12-03HANGZHOU ISLAND XINGQING BIOTECHNOLOGY CO LTD

Patent Information

Application Number
CN202411563853.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-11-05
Publication Date
2024-12-03
Estimated Expiration
2044-11-05

AI Technical Summary

Technical Problem

The existing olafluoride synthesis method uses tallow as the starting material, resulting in impurity of the olafluoride derivatives produced, affecting the accuracy of the quality standards of the end product and the analysis method.

Method used

R-X reacts with 1,3-propanediamine, followed by reaction with Lewis acid and hydroxyalkylation reagent, and finally with hydrofluoric acid to produce high-purity olafluoride derivatives, by optimizing reaction conditions and steps, including Temperature control and solvent selection ensure high purity and high yield of the product.

Benefits of technology

The synthesis of high-purity olafluoride derivatives is achieved, which reduces production costs, provides high-purity reference products, and ensures product quality control and use safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119059922A_ABST
    Figure CN119059922A_ABST
Patent Text Reader

Abstract

The invention discloses a synthetic method of an oxilafluorine derivative, which comprises the following steps: taking R-X as a raw material, reacting with 1, 3-propane diamine, adding Lewis acid and a solvent into the obtained product, reacting with a hydroxyalkylation reagent, and reacting the obtained product with hydrofluoric acid to obtain the oxilafluorine derivative. The synthesis method is simple in process, the cost is reduced, the obtained product is high in yield and high in purity, the product can be used as a reference substance for quality research and quality control of the oxilafluorine, guidance is provided for impurity content control of the product, and a guarantee is provided for use safety of the oxilafluorine.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of organic synthesis, and particularly relates to a method for synthesizing an olafluanid derivative. Background Art

[0002] Olafur (English name: Olafur, CAS No: 6818-37-7) is an important organic ammonium fluoride compound and is widely used in the field of oral care. Patent US6464962 discloses a currently commercialized method for synthesizing Olafur, and its synthesis route is as follows: The method starts with beef tallow, which is hydrolyzed to obtain stearic acid, which is then converted into the corresponding amide, which is catalytically reduced to a primary amine; then it is added with acrylonitrile and reduced to obtain N-alkyl-1,3-propylenediamine; the two nitrogen atoms react with ethylene oxide to form a tertiary amine; finally, hydrofluoric acid is added to obtain the final product. Since the starting material beef tallow used is a mixture, it is mixed with many other components, especially palmitic acid (16 carbon atoms) and oleic acid (monounsaturated fatty acid) with high content, which are also synthesized into olaflu derivatives (olaflu derivative A and olaflu derivative B) through this synthetic route. These derivatives not only affect the purity of the final product, but also affect the research and formulation of its quality standards.

[0003] Patent CN118150729A reports a method for detecting oraflu in toothpaste using an oraflu mixture reference substance containing oraflu derivative A (C16-AMF) and derivative B (C18:1-AMF). However, using a mixture as a reference substance will affect the accuracy of the analytical method, so it is necessary to provide a qualitative and quantitative high-purity analytical reference substance for the quality study of oraflu. Summary of the invention

[0004] The present invention aims to provide a method for synthesizing an olafluanid derivative, which can obtain an olafluanid derivative with high purity, so that the olafluanid derivative can be used as a standard reagent or reference substance for quality control of the olafluanid.

[0005] The method for synthesizing an olafluanid derivative provided by the present invention comprises the following steps: Step 1: RX is used as a raw material and reacted with 1,3-propylenediamine to obtain ; Step 2, Add Lewis acid and solvent, react with hydroxyalkylating agent to obtain ; Step 3, Reaction with hydrofluoric acid to obtain olaflurane derivatives ; In the above steps, The R group is or ; The X group is halogen, hydroxyl or sulfonyloxy; The hydroxyalkylating agent is one or more of ethylene oxide, 2-chloroethanol, 2-bromoethanol or 2-fluoroethanol; Preferably, in step 1 of the synthesis method: (1) When X represents a halogen, it is selected from any one of chlorine, bromine and iodine; when X represents a sulfonyloxy group, it is selected from any one of methanesulfonyloxy, benzenesulfonyloxy and p-toluenesulfonyloxy; (2) Additional solvent may or may not be added during the reaction. If added, the solvent is selected from any one of acetonitrile, water, ethyl acetate, 2-methyltetrahydrofuran, tetrahydrofuran, methanol, ethanol, tert-butanol, dichloromethane or chloroform; (3) The molar ratio of RX to 1,3-propylenediamine is 1:(1-20), preferably 1:(8-12); (4) The reaction is carried out at 60-80°C until the reaction is complete; (5) After the reaction is completed, the intermediate product can be purified by two methods: adding water to the reaction system for crystallization, filtering, taking the solid, and drying to obtain the intermediate product; or removing 1,3-propylenediamine from the reaction solution, adding ethyl acetate and sodium carbonate aqueous solution for crystallization, filtering to retain the solid, and drying to obtain the intermediate product; Preferably, in step 2 of the synthesis method: (1) The Lewis acid is selected from any one or more of tetraalkyl titanate, zinc chloride, ferric chloride, calcium chloride, aluminum chloride, boron trifluoride or magnesium chloride; (2) The molar ratio of the hydroxyalkylating agent is 1:(5-15), and the molar ratio of the Lewis acid is 1:(0.1-3), preferably 1:(8-12); (3) The solvent is selected from any one of acetonitrile, water, ethyl acetate, 2-methyltetrahydrofuran, tetrahydrofuran, methanol, ethanol, tert-butanol, dichloromethane or chloroform; (4) The reaction is carried out at 20-30°C until the reaction is complete; (5) After the reaction is completed, the reaction solution obtained by reacting N-octadecyl-1,3-dipropylamine with a hydroxyalkylating agent in the presence of a Lewis acid is washed with saturated brine and ammonia water in sequence, and concentrated to obtain an intermediate product; Preferably, in step 3 of the synthesis method: (1) The molar ratio with hydrofluoric acid is 1:(2~3); (2) The reaction process is carried out in the presence of a solvent, wherein the solvent is selected from any one or more of water and ethanol; (3) The reaction is carried out at 10-20°C until the reaction is complete; The beneficial effects of the present invention are as follows: the present invention provides a method for synthesizing an olafluanid derivative, using a new synthetic route. The synthetic method has a simple process, reduces costs, and obtains a product with high yield and high purity. The product can be used as a reference for olafluanid quality research and quality control, provides guidance for controlling the impurity content of the product, and further provides a guarantee for the safe use of olafluanid. BRIEF DESCRIPTION OF THE DRAWINGS

[0006] In order to more clearly illustrate the technical solution of the embodiment of the present invention, the following briefly introduces the drawings required for describing the embodiment, wherein: Figure 1 This is the NMR spectrum of olaflurane derivative A; Figure 2 This is the liquid phase spectrum of the olaflurane derivative A; Figure 3 This is the NMR spectrum of olaflurane derivative B; Figure 4 This is the liquid phase spectrum of olaflurane derivative B. DETAILED DESCRIPTION

[0007] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the specific implementation methods of the present invention are described in detail below in conjunction with specific embodiments.

[0008] Embodiment 1: Synthesis of Olaflurane Derivative A: Reaction step 1: When X is Br, 1-bromohexadecane (3053.14 mg, 10.00 mmol) and 1,3-propylenediamine (7410.7 mg, 100.00 mmol) were added to the reaction vessel, heated to 75°C and stirred for 15 hours, cooled to room temperature, added with water (30 mL), stirred at room temperature for 1 hour, filtered to collect the solid, washed with water and dried to obtain the intermediate product N 1 -Hexadecylpropane-1,3-diamine (2825.06 mg, yield 94.6%).

[0009] Table 1 Results of condition screening of derivative A step 1 Reaction step 2: N 1 -Hexadecylpropane-1,3-diamine (1493.16 mg, 5.00 mmol), anhydrous zinc chloride (1363.15 mg, 10.00 mmol, 2eq), and tetrahydrofuran (20 mL) were added to the reaction vessel, 2-bromoethanol (6251.26 mg, 50.00 mmol) was added dropwise at 20°C and stirred for 24 hours, saturated brine was added for washing, the solvent was removed under reduced pressure, dichloromethane and saturated sodium carbonate aqueous solution were added, extraction was performed, the organic phase was retained, and it was concentrated under reduced pressure to obtain the intermediate product 2,2'-((3-(hexadecyl(2-hydroxyethyl)amino)propyl)imino)bis(ethane-1-ol) (2073.82 mg, yield 96.3%).

[0010] Table 2 Results of condition screening of derivative A step 2 Reaction step 3: Dissolve 2,2'-((3-(hexadecyl(2-hydroxyethyl)amino)propyl)imino)bis(ethane-1-ol) (1100 mg, 2.55 mmol) in water (30 mL), control the temperature at 10-20°C, prepare hydrofluoric acid (255.52 mg, 5.11 mmol, 2eq) into a 40% aqueous solution and add it dropwise to the above reaction solution, detect the pH value, and make the pH value of the reaction system between 4 and 5. After the addition is completed, stir at 10-20°C for 2 hours, and concentrate under reduced pressure to a solid to obtain the product 2,2'-((3-(hexadecyl(2-hydroxyethyl)amino)propyl)imino)bis(ethane-1-ol) hydrofluoride (1166.89 mg, yield 97.3%). See the attached NMR spectrum of olaflurane derivative A. Figure 1 , liquid phase spectrum see attached Figure 2 .

[0011] Table 3 Results of condition screening in step 3 of derivative A Embodiment 2: Synthesis of Olaflurane Derivative B: Reaction step 1: When X is Br, the reaction process is similar to step 1 of the olaflurane derivative A. The starting material 1-bromohexadecane is replaced with (Z)-1-bromo-9-octadecene (3000.51 mg, 9.05 mmol) and 1,3-propylenediamine (6706.06 mg, 90.50 mmol) which are added to the reaction vessel. The temperature is raised to 75°C and stirred for 15 hours. The temperature is cooled to room temperature, and water (30 mL) is added. The mixture is stirred at room temperature for 1 hour. The solid is collected by filtration, washed with water, and dried to obtain the product (Z)-N 1 -(Octadeca-9-en-1-yl)propane-1,3-diamine (2656.80 mg, yield 90.4%).

[0012] Table 4 Results of condition screening of derivative B step 1 Reaction step 2:

[0013] The reaction process refers to step 2 of olafluanid derivative A, and the starting material N 1 -hexadecylpropane-1,3-diamine was replaced by (Z)-N 1 -(Octadeca-9-en-1-yl)propane-1,3-diamine (1500.05 mg, 4.62 mmol), anhydrous zinc chloride (1256.03 mg, 9.24 mmol, 2.0 eq) and tetrahydrofuran (20 mL) were added to a reaction vessel, 2-bromoethanol (5777.48 mg, 46.21 mmol) was added dropwise at 20°C and stirred for 24 hours, saturated brine was added for washing, the solvent was removed under reduced pressure, dichloromethane and saturated sodium carbonate aqueous solution were added, extraction was performed, the organic phase was retained, and it was concentrated under reduced pressure to obtain the product (Z)-2,2'-((3-((2-hydroxyethyl)(octadeca-9-en-1-yl)amino)propyl)imino)bis(ethane-1-ol) (1884.89 mg, yield 94.7%).

[0014] Table 5 Results of condition screening of step 2 of derivative B Reaction step 3: The reaction process refers to step 3 of the olafluran derivative A, and the starting material 2,2'-((3-(hexadecyl(2-hydroxyethyl)amino)propyl)imino)bis(ethane-1-ol) is replaced with (Z)-2,2'-((3-((2-hydroxyethyl)(octadec-9-en-1-yl)amino)propyl)imino)bis(ethane-1-ol) (1000.11 mg, 2.19 mmol), which is dissolved in water (30 mL), and the temperature is controlled at 10-20°C. Hydrofluoric acid (219.11 mg, 4.38 mmol) is prepared into a 40% aqueous solution and added dropwise to the above reaction solution. The pH value is detected to make the pH value of the reaction system between 4 and 5. After the addition was completed, the mixture was stirred at 10-20°C for 2 hours and concentrated under reduced pressure to a solid to obtain the product (Z)-2,2'-((3-((2-hydroxyethyl)(octadec-9-en-1-yl)amino)propyl)imino)bis(ethane-1-ol) hydrofluoride (1039.83 mg, yield 95.6%). The NMR spectrum of olafluran derivative B is attached. Figure 3 , liquid phase spectrum see attached Figure 4 .

[0015] It should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solutions of the present invention may be modified or replaced by equivalents without departing from the spirit and scope of the technical solutions of the present invention, which should all be included in the scope of the claims of the present invention.

Claims

1. A method for synthesizing an olafluanid derivative, characterized in that: include, Step 1: Take RX as raw material and react with 1,3-propylenediamine to obtain ; Step 2: Add Lewis acid and solvent to the product obtained in step 1, and react with a hydroxyalkylating agent to obtain ; Step 3: The product obtained in step 2 is reacted with hydrofluoric acid to obtain an olaflurane derivative ; Among them, the R group is or , The X group is halogen, hydroxyl or sulfonyloxy, The hydroxyalkylating agent is any one or more of ethylene oxide, 2-chloroethanol, 2-bromoethanol or 2-fluoroethanol.

2. The method for synthesizing the olafluanid derivative according to claim 1, characterized in that: In step 1, when X is halogen, it is selected from any one of chlorine, bromine and iodine; when X is sulfonyloxy, it is selected from any one of methanesulfonyloxy, benzenesulfonyloxy and p-toluenesulfonyloxy.

3. The method for synthesizing an olafluanid derivative according to claim 1 or 2, characterized in that: In step 1, the molar ratio of RX to 1,3-propylenediamine is 1:(1-20); during the reaction of step 1, a solvent may or may not be added. When a solvent is added, the solvent is selected from any one of acetonitrile, water, ethyl acetate, 2-methyltetrahydrofuran, tetrahydrofuran, methanol, ethanol, tert-butanol, dichloromethane or chloroform; the reaction temperature in step 1 is 60-80°C.

4. The method for synthesizing an olafluanid derivative according to claim 1 or 2, characterized in that: In step 2, the Lewis acid is selected from any one or more of tetraalkyl titanate, zinc chloride, ferric chloride, calcium chloride, aluminum chloride, boron trifluoride or magnesium chloride.

5. The method for synthesizing an olafluanid derivative according to claim 1 or 2, characterized in that: In step 2, the molar ratio of the product obtained in step 1 to the hydroxyalkylating agent is 1:(5-15), and the molar ratio of the product obtained in step 1 to the Lewis acid is 1:(0.1-3).

6. The method for synthesizing an olafluanid derivative according to claim 1 or 2, characterized in that: In step 2, the solvent is selected from any one of acetonitrile, water, ethyl acetate, 2-methyltetrahydrofuran, tetrahydrofuran, methanol, ethanol, tert-butanol, dichloromethane or chloroform.

7. The method for synthesizing an olafluanid derivative according to claim 1 or 2, characterized in that: In step 2, the reaction temperature is 20-30°C.

8. The method for synthesizing an olafluanid derivative according to claim 1 or 2, characterized in that: In step 3, the molar ratio of the product obtained in step 2 to hydrofluoric acid is 1:(2~3).

9. The method for synthesizing an olafluanid derivative according to claim 1 or 2, characterized in that: In step 3, the reaction temperature is 10-20°C.

10. The method for synthesizing an olafluanid derivative according to claim 1 or 2, characterized in that: In step 3, the reaction process is carried out in the presence of a solvent, and the solvent is selected from any one or more of water and ethanol.

Citation Information

Patent Citations

  • Detection method of oxilafluorine

    CN118150729A

  • Synthetic method of oxia fluorine compound

    CN118496111A

  • Synthetic method of oxilafluorine

    CN118530128A

  • Synthetic method of oxilafluorine

    CN118791391A

  • Dental care agent

    EP2450028A2

Cited By

  • Method for preparing oxilafluorine analogue with alkyl chain of C16: 1

    CN120574141A

  • Preparation method for high-purity olaflur raw material

    WO2026086532A1